FRET-based sensors for the human M 1-, M 3-, and M 5-acetylcholine receptors

• Published in: Bioorganic & medicinal chemistry Vol. 19; no. 3; pp. 1048 - 1054
• Main Authors: Ziegler, Nicole, Bätz, Julia, Zabel, Ulrike, Lohse, Martin J., Hoffmann, Carsten
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.02.2011
• Subjects: FlAsH-EDT 2; FRET; GPCR; Muscarine acetylcholine receptor; Receptor activation; OxoM; FlAsH-EDT 2; mACh; CFP; Carb; DMEM; Receptor activation; FCS; GPCR; Muscarine acetylcholine receptor; FRET; HBSS; FlAsH
• ISSN: 0968-0896; 1464-3391
• DOI: 10.1016/j.bmc.2010.07.060

Based on the recently developed approach to generate fluorescence resonance energy transfer (FRET)-based sensors to measure GPCR activation, we generated sensor constructs for the human M 1-, M 3-, and M 5-acetylcholine receptor. The receptors were labeled with cyan fluorescent protein (CFP) at their C-terminus, and with fluorescein arsenical hairpin binder (FlAsH) via tetra-cysteine tags inserted in the third intracellular loop. We then measured FRET between the donor CFP and the acceptor FlAsH in living cells and real time. Agonists like acetylcholine, carbachol, or muscarine activate each receptor construct with half-maximal activation times between 60 and 70 ms. Removal of the agonist caused the reversal of the signal. Compared with all other agonists, oxotremorine M differed in two major aspects: it caused significantly slower signals at M 1- and M 5-acetylcholine receptors and the amplitude of these signals was larger at the M 1-acetylcholine receptor. Concentration–response curves for the agonists reveal that all agonists tested, with the mentioned exception of oxotremorine M, caused similar maximal FRET-changes as acetylcholine for the M 1-, M 3- and M 5-acetylcholine receptor constructs. Taken together our data support the notion that orthosteric agonists behave similar at different muscarinic receptor subtypes but that kinetic differences can be observed for receptor activation.